혈관조영 스위트(Angio Suite) : 시장 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The angio suites market is expected to register a CAGR of 8.9% over the forecast period.

The sudden outbreak of the COVID-19 pandemic impacted most of the business sectors, including the angio suites market. Heart disease patients with COVID-19 experience various issues associated with their cardiac health. For instance, as per the article published in July 2022 in the Journal of Invasive Cardiology, the COVID-19 virus had several negative effects on the endothelium, vascular system, and heart, most of which are proinflammatory and prothrombotic. As a result, complications such as deep venous thrombosis, pulmonary embolism, stroke, and acute myocardial infarction (AMI) were likely to occur during the first month of active disease. Hence, such cardiac complications were likely to increase the demand for angio suites during the pandemic. At present, the market has reached its pre-pandemic nature in terms of demand for angio suits due to an increase in cardiac complications and various technological advancements and is expected to witness strong growth in the coming years.

The increasing burden of the geriatric population, cardiovascular diseases, the growing need for minimally invasive surgeries, and rapid technological advancements in diagnostic imaging are among the major factors expected to intensify the growth of the angio suites market.

According to the World Population Prospects 2022 report published by the United Nations, in 2022, there were 771 million people aged 65 years or over globally. The older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. Since the geriatric population is more prone to getting cardiovascular diseases and other chronic illnesses, the rise in the geriatric population is likely to increase the demand for angio suites, which is anticipated to drive market growth. Furthermore, a rise in cardiac complications among the global population is expected to increase the demand for angio suites over the forecast period. For instance, according to the February 2023 update by AIHW, there were 146,000 coronary angiography procedures reported for patients admitted to hospitals in Australia, 97,200 (67%) for males and 48,900 (33%) for females during 2021-22. Hence, the rise in angiography procedures in various regions is expected to fuel market growth. Moreover, an increase in research studies focused on angio suites is likely to depict the advantages offered by the suites and thereby boost market growth. For instance, as per the article published in October 2022 in ScienceDirect, several improvements in angiographic imaging systems technology provide options to decrease radiation exposure. The researchers showed that image resolution was perceived to be better with cine angiography (CA) compared to fluoroscopic capture (FC), although not significantly affected by beam angulation or table height.

Hence, due to the high prevalence of cardiac complications and the increase in the utilization of angio suits, the studied market is expected to witness significant growth over the forecast period. However, the high cost of the installation of the angio suite is expected to restrain the market growth.

Angio Suites Market Trends

Angioplasty by Application Segment is Expected to Witness Growth Over the Forecast Period

Angioplasty is a procedure that is used to open blocked coronary arteries caused by coronary artery disease. The angioplasty segment is anticipated to witness significant growth over the forecast period owing to the rising prevalence of cardiovascular diseases and the increase in angioplasty surgeries conducted across the world. For instance, in December 2022, an International Summit on Complex High-Risk Indicated Procedures (CHIP), focussing on advanced coronary angioplasty techniques in very high-risk patient populations, was conducted in Kochi, Kerala. During the summit, laser angioplasty was introduced in Kerala.

Furthermore, as per America's Health Ranking 2022 annual report, 8% of adults in the United States were reportedly told by a health professional that they had angina or coronary heart disease in 2021. The burden of heart and circulatory disease worldwide has been more prevalent recently, which is expected to utilize the angioplasty treatment and thereby boost the segment growth. Moreover, angioplasty leaves fewer scars, provides reduced side effects from the surgery, has a higher success rate, involves minimal invasion, and ensures speedy recovery; the above factors are majorly responsible for its popularity among patients and healthcare professionals. Hence, new advances and technologies introduced to angioplasty are expected to drive market growth. For instance, in April 2022, the Rotapro Rotational Atherectomy System was launched in India, and Medica Superspecialty Hospital in Kerala cured a 70-year-old suffering from Triple Vessel disease with the use of the Rotapro Rotational Atherectomy system. Rotapro is a hand-operated system, and with the aid of this sophisticated device, patients can undergo safe ablation and have the challenging angioplasty procedure simplified, enabling them to leave the hospital in less than 24 hours.

Thus, due to the high prevalence of cardiac complications and the increase in the utilization of angioplasty treatment, the studied segment is expected to witness significant growth over the forecast period.

North America Anticipated to Hold a Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant share of the market owing to the increasing number of investments, technological advancements, and the increased burden of cardiovascular and other chronic diseases in the region. For instance, according to the American Heart Association, by 2030, 40.5% of the United States population is expected to suffer from cardiovascular disease. This increasing burden of CVDs is anticipated to drive the growth of the studied market in the region.

Adding to that, as per a press release in July 2021, the governments of Canada and Quebec publicized their plans to invest in 209 infrastructure projects to modernize, redevelop, and upgrade health and social services institutions in Quebec, including hospitals, residential and long-term care centers, local community service centers, and rehabilitation centers. The federal Minister of Infrastructure and Communities and Minister of Health and Social Services reported a total of USD 188.3 million in funding for these 209 infrastructure projects. As a result of the development of the infrastructure of hospitals and the implementation of advanced medical devices, the angio suites market is expected to witness significant growth in the studied region.

Therefore, due to the high prevalence of cardiac complications and the increase in investments by the governments, North America is expected to witness significant growth over the forecast period.

Angio Suites Industry Overview

The angio suites market is fragmented in nature due to the presence of a number of companies globally. The studied market consists of several international as well as local companies that hold the majority of the market shares and are well known, including Siemens Healthcare GmbH, Canon Medical Systems Corporation, GE Healthcare, Koninklijke Philips NV, Carestream Health, and Shimadzu Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Geriatric Population Coupled with Cardiovascular Diseases
  • 4.2.2 Growing Demand for Minimally Invasive Surgeries and Rise in Technological Advances in Angio Suites
• 4.3 Market Restraints
  • 4.3.1 High Cost Associated with Installation
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Type
  • 5.1.1 Biplane Angio Suites
  • 5.1.2 Single Plane Angio Suites
• 5.2 By Application
  • 5.2.1 Angioplasty
  • 5.2.2 Therapeutic Stenting
  • 5.2.3 Angiograms
  • 5.2.4 Obstruction Bypass
  • 5.2.5 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Siemens Healthcare GmbH
  • 6.1.2 Canon Medical Systems Corporation
  • 6.1.3 GE Healthcare
  • 6.1.4 Koninklijke Philips N.V.
  • 6.1.5 Carestream Health
  • 6.1.6 Shimadzu Corporation
  • 6.1.7 FUJIFILM Corporation
  • 6.1.8 ESAOTE SPA
  • 6.1.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 6.1.10 Hologic, Inc.
  • 6.1.11 PLANMED OY
  • 6.1.12 IMRIS
  • 6.1.13 3D Systems, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS